Practical implications of the revised guidelines for inpatient glycemic control

Area of Science:

• Endocrinology
• Hospital Medicine
• Diabetes Management

Background:

• Hyperglycemia in hospitalized patients is linked to poor outcomes.
• Recent evidence shows inconsistent results with euglycemia interventions and potential harm from hypoglycemia.

Purpose of the Study:

• To present revised consensus guidelines for inpatient glycemic management.
• To establish safe, achievable blood glucose (BG) targets and protocols.
• To minimize risks of hyperglycemia and hypoglycemia in hospitalized patients.

Main Methods:

• Review of recent clinical evidence and observational data.
• Development of revised consensus statement by the American Association of Clinical Endocrinologists and American Diabetes Association.
• Identification of specific BG targets and therapeutic strategies for different patient populations.

Main Results:

• Intravenous insulin recommended for critically ill patients with BG > 140 mg/dl (target 140-180 mg/dl).
• Lower BG targets (110-140 mg/dl) considered for post-cardiac/vascular surgery patients.
• Scheduled subcutaneous basal:bolus insulin preferred for noncritically ill patients (fasting/preprandial < 140 mg/dl, random < 180 mg/dl).

Conclusions:

• Modified glycemic targets promote a rational approach to inpatient BG management.
• Correctional insulin monotherapy is discouraged; oral/injectable agents have limited roles.
• Effective implementation requires personnel education, reliable BG monitoring, and standardized protocols.